IO Investigación has acquired GESOP
IO Investigación has acquired a 49% stake in GESOP. This transaction enables IO Investigación to enter the high-growth public administration sector and establish a presence in Catalonia, Spain, where it plans to expand operations and grow its client network in the coming years.
Founded in 1995, IO Investigación is an independent company specializing in market research, panel services, commercial marketing and field force solutions. It serves clients across various sectors, including consumer electronics, telecommunications, financial services, insurance and retail.
GESOP is a Barcelona-based company dedicated to research, social studies and public opinion, with a focus on the public sector.
Oaklins’ team in Spain acted as the financial advisor to the bidder, IO Investigación, on all aspects of the transaction’s execution.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Aprenda másFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Aprenda másBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Aprenda más